Evidence map›Paper›PMID 30153656›Full record

ArticleAging2018

p62 /SQSTM1 coding plasmid prevents age related macular degeneration in a rat model.

Nataliya G Kolosova, Oyuna S Kozhevnikova, Darya V Telegina, Anzhela Zh Fursova, Natalia A Stefanova, Natalia A Muraleva, Franco Venanzi, Michael Y Sherman, Sergey I Kolesnikov, Albert A Sufianov and 2 more

Open access · greenAbstract read
In one paragraph

Article in Aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Proteostasis in aging-associated ocular disease.Molecular aspects of medicine · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Nataliya G Kolosova *Institute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Oyuna S Kozhevnikova *Institute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Darya V TeleginaInstitute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Anzhela Zh FursovaInstitute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Natalia A StefanovaInstitute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Natalia A MuralevaInstitute of Cytology and Genetics, SB RAS, Novosibirsk, Russia.
Franco VenanziSchool of Biosciences, University of Camerino, Camerino, Italy.
Michael Y ShermanDepartment of Molecular Biology, Ariel University, Ariel, Israel.
Sergey I KolesnikovRussian Academy of Sciences, Moscow, Russia.
Albert A SufianovSechenov First Moscow State Medical University, Moscow, Russia.
Vladimir L GabaiCureLab Oncology, Inc, Deadham, MA 02492, USA.
Alexander M ShneiderCureLab Oncology, Inc, Deadham, MA 02492, USA.
Siberian Branch of the Russian Academy of Sciences · RUAriel University · ILBoston University · USInstitute of Cytology and Genetics · RUScientific Center of Family Health Problems and Human Reproduction · RUSechenov University · RUUniversità di Camerino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P62/SQSTM1, a multi-domain protein that regulates inflammation, apoptosis, and autophagy, has been linked to age-related pathologies. For example, previously we demonstrated that administration of p62/SQSTM1-encoding plasmid reduced chronic inflammation and alleviated osteoporosis and metabolic syndrome in animal models. Herein, we built upon these findings to investigate effect of the p62-encoding plasmid on an age-related macular degeneration (AMD), a progressive neurodegenerative ocular disease, using spontaneous retinopathy in senescence-accelerated OXYS rats as a model. Overall, the p62DNA decreased the incidence and severity of retinopathy. In retinal pigment epithelium (RPE), p62DNA administration slowed down development of the destructive alterations of RPE cells, including loss of regular hexagonal shape, hypertrophy, and multinucleation. In neuroretina, p62DNA prevented gliosis, retinal thinning, and significantly inhibited microglia/macrophages migration to the outer retina, prohibiting their subretinal accumulation. Taken together, our results suggest that the p62DNA has a strong retinoprotective effect in AMD.

Indexed as

Genetic TherapyAgingAnimalsDNAGene Expression RegulationHumansMacular DegenerationMalePlasmidsRatsRats, Inbred StrainsSequestosome-1 ProteinDNASequestosome-1 ProteinSqstm1 protein, ratage-related macular degenerationaginggliosisinflammationOXYS ratsp62/SQSTM1retina

Identifiers

PMID30153656
PMCPMC6128417
OpenAlexW2889047806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.